Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Bevacizumab biosimilar for treating different types of cancers
Drug guidance

Bevacizumab biosimilar for treating different types of cancers

Cancer

12 July 2022

Guidance Recommendations

Subsidy status

Back to top